Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
AssigneeCompass Pathfinder Limited
InventorsDerek John LONDESBROUGH, Christopher BROWN, Julian Scott NORTHEN, Gillian MOORE, David E. NICHOLS
Life of this patent
Estimating the term…
Abstract
This invention relates to the large-scale production of psilocybin for use in medicine. More particularly, it relates to a method of obtaining high purity crystalline psilocybin, particularly, in the form of Polymorph A. It further relates to a method for the manufacture of psilocybin and intermediates in the production thereof and formulations containing psilocybin.
Claims20
A method of treating treatment-resistant depression in a subject in need thereof, the method comprising administering to a subject in need thereof a solid pharmaceutical composition comprising 25 mg of psilocybin, wherein the solid pharmaceutical composition comprises an Acceptance Value (AV) of less than 15 and a percentage of a label claim of greater than 90%.
A solid pharmaceutical composition comprising 25 mg of psilocybin, wherein the pharmaceutical composition comprises an Acceptance Value (AV) of less than 15 and a percentage of a label claim of greater than 90%.
Dependencies are inferred from the claim text.